By The Stem Cellar –
The California Institute for Regenerative Medicine (CIRM) is proud to announce the allocation of $26 million to support clinical research targeting a range of cancers, heart conditions, and rare diseases. This significant funding underscores CIRM’s commitment to advancing innovative stem cell and gene therapy-based treatments through all stages of clinical trial development.
This latest round of awards will support five projects within CIRM’s Clinical program, which aims to provide critical funding for eligible projects at various stages of their development.
